Cipla
PharmaMid capNSE: CIPLA · ₹1.22 L Cr market cap
₹1,516
+0.21%Price chart
Simulated series for demonstration
About the company
Cipla operates in the pharma sector and is classified as a mid-cap company with a market capitalisation of ₹1.22 L Cr. Reported return on equity is 18.3% with revenue growth of 22.3% and a debt-to-equity ratio of 1.16. Company descriptions and figures shown here are sample data for demonstration.
Volume
357 L
Beta
1.45
Dividend yield
3.79%
6M momentum
6.4%
Analyst context
Aggregated sample view
- Coverage24 analysts
- Consensus stanceMixed
- Range of estimates1,289–1,819
Analyst estimates describe other people's expectations. They are not a forecast by ArthVue and are not a recommendation.
Market investments are subject to market risks. Past performance is not indicative of future results. Nothing here is investment advice.